期刊文献+

系统性红斑狼疮患者血清MMP-3与TIMP-1的检测

The measurement of MMP-3 and TIMP-1 serum level in patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-3(MMP-3)以及金属蛋白酶组织抑制因子-1(TIMP-1)在系统性红斑狼疮(SLE)中的作用和意义。方法:采取双抗体夹心ELISA法检测45名SLE患者及30名正常对照者血清MMP-3、TIMP-1水平。结果:①与正常对照组相比患者血清MMP-3水平明显增高(P<0.01);经糖皮质激素治疗后血清MMP-3浓度下降(P<0.01)。②SLE患者中血清MMP-3水平活动组高于非活动组(P<0.05),肾损害组、肺炎组、抗ds-DNA阳性组高于对照组(P<0.01),低补体C3血症者及低血清白蛋白血症者血清MMP-3水平高于非低补体C3血症者及低血清白蛋白血症者(P<0.05)。关节炎与非关节炎患者血清MMP-3水平差异无显著性(P>0.05)。③血清TIMP-1水平在SlE组与对照组、SLE相关各组间差异均无显著性(P>0.05)。④患者血清MMP-3水平与SLE疾病活动指数SLEDAI呈正相关(P<0.01),与TIMP-1无明显相关性(P>0.05)。结论:MMP-3可能参与SLE发病机制。 Objective: To explore the clinical significance of serum matrix metalloproteinase-3(MMP-3) and tissue inhibitor of metalloproteinase-1(TIMP-1) in patients with systemic lupus erythematosus(SLE).Methods: The serum concentration of MMP-3 and TIMP-1 were measured by ELISA in systemic lupus erythematosus patients and healthy controls.Results: Firstly,the serum levels of MMP-3 in SLE patients were significantly higher as compared with that in healthy controls(P0.01).After treatment with steroid,serum MMP-3 levels were markedly decresed.Secondly in patients with active SLE and renal involvement,pulmonary involvement,decreased C3 levels,hypoalbuminemia,anti-ds-DNA positive,serum MMP-3 levels were makedly increased than those of inactive SLE and without renal involvement,pulmonary involvement,decreased C3 level,hypoalbuminemia and anti-ds-DNA negative respectively.Serum MMP-3 levels had no significant difference in patients with arthritis and without.Thirdly,serum TIMP-1 levels did not show significant difference betwen patients with SLE and healthy controls and betwen different groups of SLE.Last,a significantly positive correlation betwen MMP-3 levels and SLEDAI scores was found in patients with SLE(P0.01),but MMP-3 had no correlation with TIMP-1(P0.05).Conclusion: MMP-3 may be involved in the pathogenesis of SLE,and MMP-3 may be used as indicators to moitor disease activity,renal damage,disease progression and improvement in SLE.
作者 黄玉成
出处 《河南医学研究》 CAS 2011年第2期179-181,共3页 Henan Medical Research
关键词 红斑狼疮 系统性 基质金属蛋白酶-3 金属蛋白酶组织抑制因子-1 lupus erythematosus systemic matrix metalloproteinase-3 tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献7

  • 1Keyszer G, Lambiri I, Nagel R, et al. Circulation levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinase -1 ( TIMP-1 ) , and mmp-1/timp-1 complex in rheumatic disease : correlation with clinical activity of rheumatic arthritis versus other surrogate markers[ J]. J Rheumatol, 1999,26(5 ) :251-258.
  • 2Kotajima L, Aotsuka S, Fujimori M, et al. Increased leves of matrix metalloproteinase-3 in sera from patients with lupus_taephritis [ J ]. Clin Exp Rheumatol, 1998,16 (4) :409-415.
  • 3Zucker S, Main N, Drew M, et al. Increased serum stromelysin-1 levels in systemic lupus erthymatosus: lack of correlation with disease activity[ J]. J rheumatol, 1999,26( 1 ) :78-80.
  • 4American College of Rheumatology Ad Hoe Committee on Systemic Lupus Erythematosus Guidelines for referral anf management of Systemic Lupus Erythematosus in adults[ J]. Arthritis Rheum ,1999,42 (2) :1785-1786.
  • 5Bombardier C, Gladman DD, Urowitz MB , et al . Derivation of the SLEDAI . A disease activity index for lupus patients[ J]. The committee on prognosis studies in SLE . Arthritis Rheum , 1992,35 (6) : 630-640.
  • 6郑敏,朱铁城.SLE患者B淋巴细胞增殖功能测定及其临床意义[J].中华皮肤科杂志,1990,23(2):90-92. 被引量:35
  • 7Zucker S, Hymowitz M, Conner C, et al. Measurement of matrix metalloproteinases and tissuse inhibitors of matalloproteinases in blood and tissuses: Clinical and experimental applications [ J]. Ann NY Acad Sci, 1999,878(3 ) :212-227.

二级参考文献1

  • 1杨锋,上海免疫学杂志,1987年,7卷,357页

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部